Publications by authors named "James T Link"

Claim this Profile
T
The oncologic burden of hepatitis C virus infection: A clinical perspective.
Harrys A Torres, Terri Lynn Shigle, Nassim Hammoudi, James T Link, Felipe Samaniego

CA Cancer J Clin· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy Progress in Mismatch Repair-Deficient Colorectal Cancer and Future Therapeutic Challenges.
James T Link, Michael James Overman

Cancer J· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.
Peer B Jacobson, Thomas W von Geldern, Lars Ohman, Marie Osterland, Jiahong Wang, James T Link

J Pharmacol Exp Ther· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes.
Thomas W von Geldern, Noah Tu, Philip R Kym, James T Link, Hwan-Soo Jae

J Med Chem· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biaryl amide glucagon receptor antagonists.
Ravi Kurukulasuriya, Bryan K Sorensen, James T Link, Jyoti R Patel, Hwan-Soo Jae

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological regulation of hepatic glucose production.
James T Link

Curr Opin Investig Drugs· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis